Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73 - PubMed (original) (raw)
Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73
Andrea Tannapfel et al. Carcinogenesis. 2008 Jan.
Abstract
p53 family proteins carry on a wide spectrum of biological functions from differentiation, cell cycle arrest, apoptosis and chemosensitivity of tumors. Conversely, N-terminally truncated p73 (DNp73) functions as a potent inhibitor of all these tumor suppressor properties, implicating its participation in malignant transformation and oncogenesis. Several reports indicated considerable up-regulation of DNp73 in hepatocellular carcinoma (HCC) that correlates with reduced survival of patients, but little is known about the functional significance of DNp73 to tumorigenesis in vivo due to the lack of an appropriate model. To address this, we generated transgenic mice in which DNp73 expression is directed to the liver by the albumin promoter. Gene expression was tested by mRNA and protein analyses. Transgenic mice exhibited prominent hepatic histological abnormalities including increased hepatocyte proliferation resulting in preneoplastic lesions (liver cell adenomas) at 3-4 months. Among 12- to 20-month-old mice, 83% of animals developed hepatic carcinoma. HCC displayed a significant increase of hyperphosphorylated inactive retinoblastoma, whereas p53-regulated inhibitors of cell cycle progression were down-regulated in the tumors. Our data firmly establish the unique oncogenic capability of DNp73 to drive hepatocarcinogenesis in vivo, supporting its significance as a marker for disease severity in patients and as target for cancer prevention. This model offers new opportunities to further delineate DNp73-mediated liver oncogenesis but may also enable the development of more effective cancer therapies.
Similar articles
- Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. Conner EA, et al. Oncogene. 2000 Oct 19;19(44):5054-62. doi: 10.1038/sj.onc.1203885. Oncogene. 2000. PMID: 11042693 - Hepatocellular carcinoma in Txnip-deficient mice.
Sheth SS, Bodnar JS, Ghazalpour A, Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani H, Lusis AJ. Sheth SS, et al. Oncogene. 2006 Jun 15;25(25):3528-36. doi: 10.1038/sj.onc.1209394. Epub 2006 Apr 10. Oncogene. 2006. PMID: 16607285 - Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Jonkers J, Rudolph KL. Lechel A, et al. Gastroenterology. 2007 Apr;132(4):1465-75. doi: 10.1053/j.gastro.2007.01.045. Epub 2007 Jan 26. Gastroenterology. 2007. PMID: 17433324 - Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF, Thorgeirsson SS. Calvisi DF, et al. Toxicol Pathol. 2005;33(1):181-4. doi: 10.1080/01926230590522095. Toxicol Pathol. 2005. PMID: 15805070 Review. - DNp73 a matter of cancer: mechanisms and clinical implications.
Buhlmann S, Pützer BM. Buhlmann S, et al. Biochim Biophys Acta. 2008 Apr;1785(2):207-16. doi: 10.1016/j.bbcan.2008.01.002. Epub 2008 Feb 12. Biochim Biophys Acta. 2008. PMID: 18302944 Review.
Cited by
- ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.
Biglari N, Soltani-Zangbar MS, Mohammadian J, Mehdizadeh A, Abbasi K. Biglari N, et al. EXCLI J. 2023 Aug 3;22:752-780. doi: 10.17179/excli2023-6277. eCollection 2023. EXCLI J. 2023. PMID: 37720239 Free PMC article. Review. - SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and Disease.
Gárate-Rascón M, Recalde M, Rojo C, Fernández-Barrena MG, Ávila MA, Arechederra M, Berasain C. Gárate-Rascón M, et al. Int J Mol Sci. 2022 Nov 2;23(21):13411. doi: 10.3390/ijms232113411. Int J Mol Sci. 2022. PMID: 36362191 Free PMC article. Review. - Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.
Chen Y. Chen Y. Dis Markers. 2022 Jun 15;2022:6410113. doi: 10.1155/2022/6410113. eCollection 2022. Dis Markers. 2022. PMID: 35756491 Free PMC article. - Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond.
Logotheti S, Richter C, Murr N, Spitschak A, Marquardt S, Pützer BM. Logotheti S, et al. Front Cell Dev Biol. 2021 Sep 28;9:737735. doi: 10.3389/fcell.2021.737735. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34650986 Free PMC article. Review. - New insights into small-cell lung cancer development and therapy.
Wang Y, Zou S, Zhao Z, Liu P, Ke C, Xu S. Wang Y, et al. Cell Biol Int. 2020 Aug;44(8):1564-1576. doi: 10.1002/cbin.11359. Epub 2020 Apr 18. Cell Biol Int. 2020. PMID: 32281704 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous